Since inactivating mutations in ADA and PNP have been associated with severe combined immunodeficiency39, but not with cancer, we focused on examining the metabolic fate of dC as the most relevant dCK substrate in ATR-inhibited T-ALL cells for salvage biosynthesis. The gene discussed is ADA; the disease is acute lymphoblastic leukemia.